Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1983-08-22
1985-03-26
Jiles, Henry R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548341, A61J 31415, C07D23354
Patent
active
045073155
ABSTRACT:
Benzamide derivatives of the general formula: ##STR1## wherein A represents a divalent straight- or branched-chain alkylene group containing from 1 to 6 carbon atoms and R.sup.1 represents a halogen atom or a hydroxy, mercapto, amino, nitro, cyano, carboxy or carbamoyl group or an alkyl, fluorine-substituted alkyl, alkoxy, alkylthio, alkylsulphinyl, alkylsulphonyl, alkoxycarbonyl, alkylamino, dialkylamino, alkylcarbamoyl, dialkylcarbamoyl, alkanoyl, alkanoyloxy or alkanoylamino group and m represents zero or the integer 1, 2 or 3, R.sup.2 represents a hydrogen atom or an alkyl group, R.sup.3 represents a halogen atom or a hydroxy, amino, nitro, cyano, carboxy or carbamoyl group or an alkyl, fluorine-substituted alkyl, alkoxy, alkoxycarbonyl, dialkylamino, alkylcarbamoyl or alkanoylamino group and n represents zero or the integer 1 or 2, R.sup.4 represents and alkyl radical and p represents zero or the integer 1 or 2, or a pharmaceutically acceptable salt thereof, possess useful pharmacological properties.
REFERENCES:
patent: 3349124 (1967-10-01), McLamore
patent: 4113871 (1978-09-01), Stach et al.
patent: 4221815 (1980-09-01), Weyer et al.
patent: 4238506 (1980-12-01), Stach et al.
patent: 4245120 (1981-01-01), Shepherd
patent: 4317915 (1982-03-01), Confalone et al.
patent: 4322439 (1982-03-01), Klemm et al.
patent: 4328155 (1982-05-01), Masaru et al.
patent: 4328344 (1982-05-01), Masaru et al.
patent: 4330472 (1982-05-01), Ogata et al.
patent: 4350635 (1982-09-01), Ogata et al.
patent: 4351770 (1982-09-01), Ogata et al.
D. Steinberg, J. Pathology, vol. 133, (1981), pp. 75-87.
Day et al., Advances in Experimental Medicine and Biology, vol. 109, (1981), pp. 277-283.
Ashton Michael J.
Bull Bernard T.
Cook David C.
Daniels Colin J.
Loveless Anthony H.
Jiles Henry R.
May & Baker Limited
Mullins J. G.
LandOfFree
Hypoglycaemic and hypolipidaemic benzamide substituted (1H-) imi does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hypoglycaemic and hypolipidaemic benzamide substituted (1H-) imi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hypoglycaemic and hypolipidaemic benzamide substituted (1H-) imi will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1293847